Platinum-sensitive Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Platinum-sensitive Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy [Phase 3]
A Phase 3 trial comparing Rina-S plus standard of care versus standard of care for maintenance therapy in recurrent platinum-sensitive ovari…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) [Phase 1, Phase 2]
Genmab is conducting a Phase 1/2 clinical trial of Rinatabart Sesutecan for multiple advanced solid tumors; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse) [Phase 2]
This is a Phase 2 clinical trial update for the RESCUE study evaluating secondary cytoreduction using chemotherapy response in recurrent, pl…